Delivering Global Health Impact Through People, Science and Technology

Emmes Group is the industry's first specialty, tech and AI based CRO, delivering programs better and faster, and helping bring new medical discoveries closer to patients.

At Emmes Group, our work is driven by a simple but profound belief: truth matters. Since our founding in 1977, we’ve been committed to uncovering truth in clinical research – through scientific rigor, operational excellence, and deep collaboration with our clients and partners. That truth fuels better decisions, faster treatments, and more confident health outcomes.

News

Article
Essex Management Appoints David Loose as Chief Executive Off…
Press Release
Mesoblast and BMT CTN to initiate pivotal trial of Ryoncil®
Article
Emmes CEO on AI in clinical research
Article
2025 DIA Annual Meeting: Why AI and Automation Are Set to Be…
Article
Navigating Funding Freezes and AI Frontiers
Article
2025 DIA Annual Meeting: Preparing Operational Teams for AI…

Our Brands

Emmes veridix vaxtrails

OptymEdgeEssex


file

RFP

Submit an RFP Document

globe

2,150+

Phase I–IV trials in
90+ countries

note

434+

Publications in scientific
journals since 2016

location

32,000+

Clinical trial sites

history

History

Founded as Emmes more than 47 years ago, Emmes Group has grown to become one of the primary clinical research providers to the US government before expanding into public-private partnerships and commercial biopharma.

leadership

Leadership

We are led by a dynamic team of visionaries who bring a wealth of experience, expertise and passion to drive our mission.

careers

Careers

Join us in shaping the future of healthcare through groundbreaking research and innovation.